Trial intelligence / Profile preview

High Dose Vitamin C Combined With Metformin in Malignant Tumors

NCT04033107Phase 2Unknown

Sponsor
Zhongnan Hospital of Wuhan University
Start
Jul 2020
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ascorbic acid, liquid metformin (Aspargo Labs) in hepatocellular carcinoma (HCC), pancreatic cancer (PC), gastric cancer (GC), colorectal cancer (CRC), sponsored by Zhongnan Hospital of Wuhan University. Status: unknown.

02

Drugs

ascorbic acidliquid metformin (Aspargo Labs)
03

Conditions

hepatocellular carcinoma (HCC)pancreatic cancer (PC)gastric cancer (GC)colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT04033107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04033107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call